{
  "ptid_time": "130_S_4660_2014-05-06",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4660/2014-05-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 23,729 mm³, 15.5% below the reference mean. With a Z-score of -0.35 (36.2th percentile), this represents normal volume ; hippocampal volume measures 4,151 mm³, 41.7% below the reference mean. With a Z-score of -3.82 (0.0th percentile), this represents profound atrophy; whole brain volume measures 842,330 mm³, 13.6% below the reference mean. With a Z-score of -1.71 (4.4th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 79.2 years. Gender is Female. Education: 16 years. MMSE: 21.0. MoCA: 18.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.61 SUVR (profound elevated); Amyloid beta: 760.00 pg/mL (normal ); Total tau: 606.60 pg/mL (profound elevated); Phosphorylated tau: 63.40 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows profound atrophy (Z-score -3.82), which is strongly associated with Alzheimer's disease (AD). The elevated T-tau, P-tau, and AV45 (amyloid PET) levels further support AD pathology, despite normal Aβ levels (which may indicate advanced disease with plaque saturation). The cognitive scores (MMSE 21, MoCA 18) are consistent with moderate cognitive impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High** (due to clear biomarker and structural evidence, along with cognitive decline)",
  "timestamp": "2025-07-26T14:51:17.330180"
}